Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3)

The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other research tools and receive funding for all activities to be conducted in their own laboratories. 

Funding: no fixed limit 

Duration: 5 years 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due dates: 9.1.24, 15.6.24, 15.12.24, 15.6.25, 15.12.25, 15.6.26

Full application due dates: 9.2.24, 15.7.24, 15.1.25, 15.7.25, 15.1.26, 15.7.26